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RESEARCH NOTE
Weight management merits attention 
in women with infertility: a cross-sectional 
study on the association of anthropometric 
indices with hormonal imbalance in a Ghanaian 
population
William K. B. A. Owiredu1, Peter Ntim Ofori2, Cornelius Archer Turpin3, Christian Obirikorang1, 
Emmanuel Acheampong4, Enoch Odame Anto4, Eddie‑Williams Owiredu1 and Evans Asamoah Adu1* 
Abstract 
Objective: This study determined the association of anthropometric indices with hormonal imbalance among infer‑
tile women in a Ghanaian population.
Results: Follicle stimulating hormone (FSH) levels (18.47 vs. 8.67, p‑value = 0.002), and luteinizing hormone (LH) 
(12.43 vs. 8.01, p‑value = 0.044) were higher in women with primary infertility compared with women presenting with 
secondary infertility. Waist circumference (WC) and waist‑to‑height ratio (WHtR) showed significant negative partial 
correlation with prolactin in both primary and secondary infertile women. Also a significant negative partial correla‑
tion was observed between BMI and prolactin in secondary infertile women only. Waist‑to‑hip ratio (WHR) showed a 
positive association with LH in both primary and secondary infertility. WHR also showed significant positive correla‑
tion to LH/FSH ratio in secondary infertility whereas body adiposity index (BAI) showed a negative correlation to LH/
FSH ratio. In a correlation analysis of anthropometric measures with hormonal profile and causes of infertility as a fixed 
factor, the association between anthropometric indices and fertility hormones was largely dependent on the underly‑
ing causes of infertility.
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Introduction
Infertility is a recognised public health issue, which is 
associated with medical, psychosocial and econom-
ics burden according to the World Health Organization 
(WHO) [1, 2]. It is a problem of global shares, affecting 
an average of 8% to 12% of couples worldwide [2]. Coun-
tries within the Sub-Saharan Africa (SSA), southern and 
central part of Africa, records as high as 30.0% preva-
lence of infertility among couples [3–5]. In Ghana, the 
prevalence rate of infertility is reportedly 11.8% among 
women and 15.8% among men [6].
Overweight/obesity influences fertility by affect-
ing ovulatory function [7]. Chang [8] indicated that the 
complex hormonal balance of the hypothalamic–pitui-
tary–gonadal axis is affected by an individual’s body mass 
index (BMI). Thus, the interplay between fertility and 
obesity is the effect of obesity on menstrual disturbances 
and subfertility, although the exact mechanism has not 
been clearly elucidated [9, 10]. Pandey et al. [9] reported 
that overweight and obese women have poorer outcomes 
following fertility treatment. Thus, highlighting the sig-
nificant effect of extreme weight on fertility especially 
among women.
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Functional redundancy of the gonadotropin releasing 
hormone (GnRH) causes disruption of the normal secre-
tion of luteinizing hormone (LH) and follicle stimulat-
ing hormone (FSH), which is involved in a number of 
reproductive disorders in women [11, 12]. Measurements 
of hormones including prolactin and thyroid stimulat-
ing hormones has a diagnostic value in the evaluation of 
women fertility function [13]. Seth et  al. [10] in recent 
years reported an association between obesity indices 
and hormonal derangements among infertile women. 
Prolactin (PRL) levels, which is significant in evaluat-
ing female fertility, may be secreted from adipose tissues 
[14]. Thus, providing a link between obesity and hyper-
prolactinemia. In Ghana, studies evaluating the effect of 
weight-related behaviours on fertility hormones are lack-
ing. Therefore, this study evaluated the association of 
anthropometric indices with hormonal imbalance among 
infertile women in a Ghanaian population.
Main text
Methods
The study was a cross-sectional study conducted at 
the Department of Obstetrics and Gynaecology at the 
Komfo Anokye Teaching Hospital. All patients visiting 
the department for infertility issues and above 18  years 
from September 2015, to March 2018 were included as 
a sample. Those who were psychologically, physically 
and socially fit after an investigation by a gynaecolo-
gist were selected to partake in the study. Women with 
infectious conditions such as human immunodeficiency 
virus (HIV), Hepatitis B and C, and Tuberculosis were 
excluded from the study. Patients on any kind of hor-
mone treatment or those with LH and FSH levels sugges-
tive of menopausal state were excluded from the study. In 
total, 184 infertile women were included.
A brief consultation was conducted and appointment 
made with participants based on knowledge of their 
last menstrual periods for blood samples to be taken for 
21-day progesterone (ng/ml), LH (mIU/ml), FSH (mIU/
ml) and PRL (ng/ml) levels. Participants were asked to 
complete a structured questionnaire which asked about 
age, and years of infertility. Causes of infertility were 
extracted from the patient’s folder. Weight (kg) of each 
participant was measured using a platform electronic 
scale. Waist and hip circumference were measured using 
non-extensible tape measure at the point of the umbili-
cus and the maximal gluteal position, respectively. A sta-
diometer was used for body height in a good standing 
posture. BMI was calculated as an index of body weight 
and height (kg/m2). WHR and WHtR were estimated 
from the ratio of waist (cm) to hip (cm) and waist (cm) 
to height (cm), respectively. Abdominal volume index 
(AVI) and BAI were calculated using the formulae by 
[15] and [16], respectively. Two millilitres fasting venous 
blood sample was drawn from the subject on the twenty-
first day of menstrual cycle using standard venepuncture 
techniques into plain vacutainers without any additive. 
Serum separated after clotting was used for the estima-
tion of fertility hormones using mini  VIDAS® Hormonal 
Analyser  (BioMerieux® SA, France).
Statistical analysis was done using Statistical package 
for Social Sciences (SPSS) version 25 for windows. Kol-
mogorov–Smirnov test was used to assess the normality 
of the data. Partial Pearson’s correlation analysis adjusted 
for age and duration of infertility were used to determin-
ing the correlation between anthropometric indices and 
hormonal factors. p-value < 0.05 was considered as statis-
tically significant.
Results
Women with secondary infertility were older compared 
with women with primary infertility (34.9 vs. 30.3 years, 
p-value < 0.0001). A higher proportions of women with 
primary infertility were young adults (79.6%) whereas 
a higher percentage of women with secondary infer-
tility were middle aged adults (51.3%). Mean FSH 
(18.47 vs. 8.67, p-value = 0.002), and LH (12.43 vs. 8.01, 
p-value = 0.044) were higher for women with primary 
infertility compared with secondary infertility, respec-
tively (Table 1).
A significant negative partial correlation was observed 
between BMI and prolactin in secondary fertility 
(R = −  0.24, p-value = 0.036). WC had a negative asso-
ciation with prolactin in both primary (R = − 0.236) and 
secondary (R = −  0.232) infertility. WHtR had a signifi-
cant negative partial correlation with prolactin in both 
primary (R = − 0.226) and secondary (R = − 0.256) infer-
tility. WHR correlated positively with LH in both primary 
(R = 0.213) and secondary (R = 0.229) infertility. Also 
WHR showed significant positive partial correlation to 
LH/FSH ratio in secondary infertility (R = 0.299). BAI 
showed a negative partial correlation to LH/FSH ratio 
(R = − 0.263) (Table 2).
WC (R = 0.45) and WHtR (R = 0.38) had a significant 
partial positive correlation to LH among patients with 
polycystic ovarian syndrome (PCOS) as the cause of 
infertility. WC and WHtR had a significantly partial cor-
relation to FSH (R = 0.64 and 0.58, respectively) among 
patients with hyperprolactinemia as the cause of infertil-
ity. Among patients with tubal cause of infertility, a signif-
icant partial negative correlation was observed between 
WC (R = − 0.53), WHtR (R = − 0.55), WHR (R = − 0.41), 
BAI (R = −  0.44) and prolactin. Also significant partial 
negative association was observed for WC, WHtR and 
BAI to FSH (R = − 0.35, − 0.33 and − 0.35, respectively) 
among patients with tubal causes of infertility. Moreover, 
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among patients with tubal causes of infertility, WHR was 
positively correlated to progesterone (R = 0.40), whereas 
WHtR showed positive correlation to LH/FSH (R = 0.34). 
Among patents with male partner being the cause of 
infertility, BMI, WC, WHR and WHtR showed significant 
negative partial correlation to progesterone. Moreover, 
BMI showed negative partial correlation to LH/FSH ratio 
(R = −  0.53). Among patients with unexplained causes 
of infertility, WC, WHtR and WHR showed a significant 
partial correlation to prolactin (Table 3).
Discussion
Our findings indicates that women with secondary infer-
tility were older and had longer duration of infertility 
compared with those with primary infertility. This find-
ing is consistent with the findings of Seth et al. [10] and 
highlights the independent role of age in fertility function 
of women [17]. This age phenomenon suggests decreased 
fecundity in secondary infertile women who have been 
successful in having their previous pregnancies. Ages 
beyond 32-years reflects decrease in egg quality in asso-
ciation with a gradual increase in circulating level of FSH, 
declines in circulating anti-müllerian hormone and inhi-
bin B concentrations [18].
One important finding of this study was that fertility 
hormones including FSH and LH were higher and above 
normal range in women with primary infertility com-
pared with secondary infertility. Additionally, although 
not significant, levels of progesterone and PRL were high 
in women with primary infertility compared with sec-
ondary infertility. This finding aligns the findings of Al-
Turki [19]. Generally, FSH stimulates several follicles to 
mature and LH kindles ovulation by causing the domi-
nant follicle to burst and release its eggs into the fallopian 
tube. High LH and FSH levels increase ovarian testoster-
one production, alter oestrogen production, and causes 
abnormalities with ovulation. The levels of LH and FSH, 
observed among primary infertile women is suggestive 
of a possible primary ovarian failure and poor pregnancy 
outcomes [18, 20].
Table 1 Basic characteristics of the study participants
All values are presented as frequency and column proportions, unless otherwise specified. Highlighted values are statistically significant
Values highlighted in italics are statistically significant
PCOS polycystic ovarian syndrome, FSH follicle stimulating hormone, LH luteinizing hormone
a Denotes values presented as mean ± standard error of mean
Variable Primary infertility
(n = 108)
Secondary infertility
(n = 76)
p-value
Duration of  infertilitya 4.0 ± 0.39 5.5 ± 0.42 < 0.0001
Age (years)a 30.3 ± 0.56 34.9 ± 0.61 < 0.0001
Age staging
 Young adults (19–34 years) 86 (79.6) 37 (48.7) < 0.0001
 Middle‑aged adults (≥ 35 years) 22 (20.4) 39 (51.3) < 0.0001
Aetiology
 Hyperprolactinemia 17 (15.7) 6 (7.9) 0.113
 Tubal factors 30 (27.8) 8 (10.5) 0.004
 Male factors 18 (16.7) 6 (7.9) 0.082
 Ovulation problems 3 (2.8) 20 (26.3) < 0.0001
 PCOS 16 (14.8) 15 (19.7) 0.380
 Endometriosis 2 (1.9) 4 (5.3) 0.200
 Uterine causes 14 (13.0) 14 (18.4) 0.310
 Unexplained causes 14 (13.0) 11 (14.5) 0.769
Body mass index (kg/m2)a 28.6 ± 0.50 29.8 ± 0.54 0.116
Waist circumference (cm)a 88.6 ± 1.07 88.2 ± 1.07 0.832
Waist‑to‑hip  ratioa 0.87 ± 0.01 0.86 ± 0.01 0.088
Waist‑to‑height  ratioa 0.56 ± 0.01 0.55 ± 0.01 0.408
Body adiposity  indexa 32.3 ± 0.50 32.5 ± 0.64 0.816
Progesterone (ng/ml)a 8.94 ± 0.58 7.52 ± 0.58 0.547
FSH (mIU/ml)a 18.47 ± 2.18 8.67 ± 1.17 0.002
LH (mIU/ml)a 12.43 ± 1.25 8.01 ± 0.97 0.044
LH/FSH  ratioa 1.00 ± 0.10 1.28 ± 0.18 0.061
Prolactin (ng/ml)a 20.41 ± 1.93 17.99 ± 1.58 0.060
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Another significant finding in this study was the direct 
association observed between LH and the central adipos-
ity index (WHR) in both primary and secondary infertile 
women. Besides, no association was observed between 
any adiposity index and FSH levels in both primary and 
secondary infertile women. This findings deviates from 
previous report, which reported a positive association 
between central adiposity indices and FSH levels but not 
LH [10]. De Pergola et al. [21] also reported an inverse of 
adiposity indices with LH and FSH levels, which deviates 
from our present finding. In our findings, central adipos-
ity indices (WC and WHtR) were positively correlated 
with LH levels among PCOS associated infertility. In line 
with a previous study [22] women with PCOS are most 
likely to have central fat distribution, which is associated 
with hyperandrogenaemia. Also, a neuroendocrine mark 
of PCOS is persistently rapid GnRH pulsatility, which 
favours pituitary synthesis of LH over that of FSH and 
contributes to the increased LH concentrations [23].
This study also observed a negative association 
between central adiposity indices (WC and WHtR) and 
prolactin levels in both primary and secondary infer-
tile women. This finding is incongruent with a previous 
finding [10], which rather observed a positive associa-
tion. The unique finding of this study was that prolac-
tin levels of women with tubal factors as the cause of 
infertility showed negative association with central 
adiposity indices (WC and WHtR). Women with unex-
plained causes of infertility showed positive association 
between WC, WHtR and prolactin levels, which sug-
gest possible obesity-induce hyperprolactinemia and 
poor fertility outcomes. Thus, we speculated that the 
association between central adiposity and prolactin lev-
els is influenced by the underlying causes of infertility 
which merits future investigations.
Among hyperprolactinemia-associated infertility, a 
positive association was found between FSH levels and 
markers of central adiposity (WC and WHtR). Hyper-
prolactinemia affects GnRH neurons and pituitary gland 
function to reduce secretion of LH and FSH, which rep-
resents an ovulatory disorder often associated with sec-
ondary amenorrhea or oligomenorrhea [24, 25]. Also, the 
interplay between fertility and obesity is the effect of obe-
sity on menstrual disturbances [9, 10]. Thus, we hypoth-
esised an investigative associations of serum measures 
of ovarian reserve and ultrasound measurements of 
antral follicle counts with body size especially in hyper-
prolactinemia-associated infertility, which could better 
expound this observation.
Our findings suggest a direct association between 
adiposity indices and various hormonal derangements, 
which is largely dependent on the aetiology of infer-
tility. Intervention undertaken to control central and 
visceral obesity would definitely provide a beneficial 
effect by correcting the hormonal imbalance. Therefore, 
we recommend that an effective weight-management 
intervention among infertile women is beneficial for 
their hormonal milieu, more appropriate for fertility.
Table 2 Partial correlation of anthropometric measures with hormonal profile in primary and secondary fertility
Values highlighted in italics are statistically significant
R partial correlation coefficient (adjusted for age and duration of condition), BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-
height ratio, BAI body adiposity index, PRG progesterone, FSH follicle stimulating hormone, LH luteinizing hormone, PRL prolactin
Variable Primary infertility Secondary infertility
PRG FSH LH PRL Ratio PRG FSH LH PRL LH/FSH
BMI
 R 0.029 − 0.028 0.025 − 0.09 0.046 0.09 0.123 0.204 − 0.24 0.218
 p‑value 0.762 0.773 0.794 0.353 0.638 0.439 0.291 0.077 0.036 0.058
WC
 R 0.061 0.03 0.178 − 0.236 0.085 0.169 − 0.039 0.013 − 0.232 0
 p‑value 0.531 0.756 0.065 0.014 0.382 0.145 0.741 0.913 0.044 0.999
WHR
 R 0.118 0.049 0.213 − 0.098 0.149 0.089 − 0.062 0.229 − 0.151 0.299
 p‑value 0.222 0.616 0.027 0.311 0.124 0.443 0.594 0.047 0.192 0.009
WHtR
 R 0.027 − 0.021 0.116 − 0.226 0.057 0.179 0.011 − 0.024 − 0.256 − 0.103
 p‑value 0.783 0.832 0.232 0.019 0.56 0.122 0.924 0.838 0.025 0.377
BAI
 R − 0.092 − 0.11 − 0.091 − 0.183 − 0.08 0.135 0.097 − 0.116 − 0.21 − 0.263
 p‑value 0.342 0.258 0.351 0.058 0.408 0.244 0.405 0.317 0.068 0.022
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Table 3 Partial correlation of anthropometric measures with hormonal profile and aetiology of infertility as a fixed factor
Values highlighted in italics are statistically significant
R partial correlation coefficient (adjusted for primary and secondary infertility), BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-
height ratio, BAI body adiposity index, PRG progesterone, FSH follicle stimulating hormone, LH luteinizing hormone, PRL prolactin
Variables Polycystic ovarian syndrome Hyperprolactinemia
PRG FSH LH PRL Ratio PRG FSH LH PRL LH/FSH
BMI
 R 0.15 0.09 0.08 − 0.07 0.14 0.11 0.40 0.33 − 0.35 0.22
 p‑value 0.433 0.646 0.667 0.714 0.465 0.637 0.065 0.134 0.111 0.321
WC
 R 0.18 0.31 0.45 − 0.15 − 0.04 0.33 0.64 0.37 − 0.40 0.27
 p‑value 0.335 0.100 0.012 0.436 0.822 0.133 0.001 0.089 0.067 0.222
WHR
 R − 0.12 0.08 0.29 − 0.10 0.14 − 0.18 0.20 0.25 − 0.12 0.27
 p‑value 0.532 0.659 0.118 0.598 0.446 0.432 0.376 0.270 0.605 0.225
WHtR
 R − 0.01 0.22 0.38 − 0.06 − 0.07 0.26 0.58 0.32 − 0.38 0.22
 p‑value 0.96 0.25 0.040 0.75 0.70 0.24 0.010 0.15 0.08 0.34
BAI
 R − 0.06 0.12 0.22 − 0.02 − 0.15 0.30 0.40 0.14 − 0.26 0.04
 p‑value 0.755 0.523 0.238 0.911 0.44 0.182 0.067 0.539 0.240 0.847
Tubal cause Ovulation cause
BMI
 R 0.30 − 0.24 − 0.17 − 0.25 − 0.01 0.08 0.01 0.00 − 0.20 0.09
 p‑value 0.068 0.160 0.327 0.130 0.957 0.731 0.951 0.985 0.372 0.692
WC
 R 0.27 − 0.35 − 0.08 − 0.53 0.31 0.13 − 0.05 − 0.02 − 0.33 0.15
 p‑value 0.113 0.036 0.655 0.001 0.060 0.559 0.821 0.915 0.140 0.515
WHR
 R 0.40 − 0.12 0.10 − 0.41 0.28 − 0.33 − 0.25 − 0.13 − 0.03 0.33
 p‑value 0.014 0.481 0.551 0.011 0.100 0.140 0.254 0.555 0.908 0.134
WHtR
 R 0.22 − 0.33 − 0.04 − 0.55 0.34 0.22 − 0.04 − 0.02 − 0.35 0.03
 p‑value 0.193 0.049 0.814 < 0.0001 0.043 0.337 0.853 0.922 0.114 0.889
BAI
 R − 0.10 − 0.35 − 0.13 − 0.44 0.23 0.53 0.25 0.19 − 0.41 − 0.23
 p‑value 0.541 0.033 0.445 0.006 0.173 0.011 0.268 0.402 0.057 0.312
Male factor Unexplained cause
BMI
 R − 0.60 0.27 − 0.04 − 0.33 − 0.54 − 0.06 − 0.06 0.08 0.20 0.28
 p‑value 0.002 0.218 0.842 0.119 0.008 0.785 0.79 0.719 0.36 0.183
WC
 R − 0.54 0.27 0.35 0.08 0.23 − 0.06 − 0.26 − 0.09 0.48 0.35
 p‑ value 0.01 0.22 0.11 0.73 0.291 0.787 0.218 0.692 0.018 0.098
WHR
 R − 0.50 0.19 0.12 − 0.15 0.03 − 0.22 0.08 0.07 0.49 0.0
 p‑value 0.02 0.40 0.59 0.505 0.878 0.307 0.72 0.743 0.014 0.986
WHtR
 R − 0.56 0.15 0.16 0.02 0.05 − 0.13 − 0.29 − 0.15 0.49 0.24
 p‑value 0.010 0.500 0.480 0.927 0.834 0.533 0.171 0.484 0.016 0.254
BAI
 R − 0.21 − 0.04 − 0.06 0.05 − 0.13 − 0.04 − 0.47 − 0.31 0.20 0.26
 p‑value 0.330 0.867 0.772 0.813 0.554 0.872 0.02 0.142 0.347 0.219
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Limitations
The lack of a control population or available anthropo-
metric national data to compare our results is a major 
limitations of our study. Also, the measurements of thy-
roid stimulating hormones, glucose and lipids as well as 
oestrogen and testosterone would have been beneficial to 
clearly explain some of the findings between obesity and 
hormone levels, which is a limitation to this study.
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